Allarity Therapeutics (ALLR) Earnings Date, Estimates & Call Transcripts

Allarity Therapeutics logo
$0.84 -0.03 (-3.91%)
Closing price 04:00 PM Eastern
Extended Trading
$0.89 +0.05 (+5.35%)
As of 04:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Allarity Therapeutics Earnings Summary

Allarity Therapeutics issued Q3 2026 earnings on November 13, 2026, reporting an EPS of -$0.39, which missed the consensus estimate of -$0.21 by $0.18. Quarterly revenue was reported to be $10 thousand, above analyst estimates of $5 thousand. With a trailing EPS of -$0.98, Allarity Therapeutics' earnings are expected to decrease next year, from ($0.75) to ($0.86) per share.

Q3 2026 Earnings Resources

Latest Q3 2026
Earnings Date
Nov. 13Estimated
Consensus EPS
(Nov. 13)
-$0.21
Actual EPS
(Nov. 13)
-$0.39 Missed By -$0.18
Actual Revenue
(Nov. 13)
$0.01M
Get Allarity Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Allarity Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

ALLR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ALLR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Allarity Therapeutics Analyst EPS Estimates & Company Guidance

Low, high and average are individual analyst estimates we track. Guidance columns are the company's own outlook, and the revenue estimate was recorded when that guidance was issued.

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany EPS Guidance
Q1 20261-$0.22-$0.22-$0.22
Q2 20261-$0.25-$0.25-$0.25
Q3 20261-$0.21-$0.21-$0.21
Q4 20261-$0.21-$0.21-$0.210.010 - 0.040
FY 20264-$0.89-$0.89-$0.89
Q1 20271-$0.22-$0.22-$0.22
Q2 20271-$0.22-$0.22-$0.22
Q3 20271-$0.22-$0.22-$0.22
Q4 20271-$0.21-$0.21-$0.21
FY 20274-$0.87-$0.87-$0.87

Allarity Therapeutics Earnings History by Quarter

Report Date
0 Results
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/13/2026Q3 2026-$0.21-$0.39 -$0.18-$0.39$0.01M$0.01M
8/14/2026Q2 2026-$0.25-$0.21+$0.04-$0.21--
5/15/2026Q1 2026-$0.22-$0.17+$0.05-$0.17$0.03M$0.03M
3/30/2026Q4 2025-$0.22-$0.21+$0.01-$0.21--
11/14/2025Q3 2025-$0.23-$0.19+$0.04-$0.19--
8/15/2025Q2 2025-$0.21-$0.15+$0.06-$0.15--
5/13/2025Q1 2025-$8.10-$0.25+$7.85-$0.25--

Allarity Therapeutics Earnings - Frequently Asked Questions

Allarity Therapeutics (NASDAQ:ALLR) last announced its quarterly earning data on Friday, November 13, 2026. Learn more on ALLR's earnings history.

Allarity Therapeutics issued an update on its fourth quarter 2026 earnings guidance on Friday, November, 13th. The company provided earnings per share (EPS) guidance of 0.010-0.040 for the period, compared to the consensus earnings per share estimate of -0.210. The company issued revenue guidance of -.

In the previous quarter, Allarity Therapeutics (NASDAQ:ALLR) missed the analysts' consensus estimate of ($0.21) by $0.18 with a reported earnings per share (EPS) of ($0.39). Learn more on analysts' earnings estimate vs. ALLR's actual earnings.

Allarity Therapeutics' earnings report can be found in their filing with the SEC.
View SEC filing

Allarity Therapeutics (NASDAQ:ALLR) has a recorded annual revenue of $320,000.00.

Allarity Therapeutics (NASDAQ:ALLR) has a recorded net income of -$11.23 million. ALLR has generated -$0.98 earnings per share over the last four quarters.

Allarity Therapeutics' earnings are expected to decrease from ($0.75) per share to ($0.86) per share in the next year.


Earnings data for NASDAQ:ALLR is sourced from Fiscal.ai, with the most recent quarter reported on 11/13/2026. New results are added as companies report their earnings.
From Our Partners